Trials / Sponsors / Cellbion Co., Ltd.
Cellbion Co., Ltd.
Industry · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Lutetium (177Lu) DGUL Combined With Pembrolizumab in Metastatic Castration-Resistant Prostate Cancer Metastatic Castration-resistant Prostate Cancer (mCRPC) | Phase 1 | 2025-12-01 |
| Active Not Recruiting | A Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, Dosimetry, and Anti-tumor Activity of Ga-68-N Prostate Cancer, mCRPC | Phase 1 / Phase 2 | 2021-04-12 |